Stock Events

Stock Events

Quest Pharmatech 

$0.03
3
+$0+0% Wednesday 14:31

Statistics

Day High
0.02
Day Low
0.02
52W High
0.03
52W Low
0.01
Volume
225,625
Avg. Volume
2
Mkt Cap
5.14M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 5
$0.05
Apr 5
$0.05
Jan 5
$0.05
Oct 4
$0.05
Jul 4
$0.05
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

12JulExpected
Q2 2022
Q2 2024
-0
0.33
0.66
1
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-2.51MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow QPTFF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines, competing directly with Quest Pharmatech in the oncology and immunotherapy sectors.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including innovative medicines and vaccines, directly competing in the biopharmaceutical field.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company is a global biopharmaceutical company with a strong portfolio in cancer treatment, immunology, and cardiovascular diseases, making it a direct competitor.
Novartis
NVS
Mkt Cap237.61B
Novartis AG focuses on patented medicines, generics, and biosimilars, with significant investments in research and development in areas overlapping with Quest Pharmatech's interests.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. is a biopharmaceutical company that researches, develops, and commercializes drugs in areas such as oncology, competing in similar therapeutic areas as Quest Pharmatech.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. is a biotechnology company focusing on cardiovascular disease, oncology/hematology, and other areas, directly competing with Quest Pharmatech in biopharmaceuticals.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. is a research-based biopharmaceutical company with a strong emphasis on immunology, oncology, and virology, areas that overlap with Quest Pharmatech's focus.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a pioneer in healthcare, focusing on pharmaceuticals and diagnostics in oncology, immunology, and infectious diseases, making it a competitor.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC is a global, science-led biopharmaceutical business that focuses on the discovery, development, and commercialization of prescription medicines, including in areas competing with Quest Pharmatech.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson is a diverse healthcare company that develops and sells pharmaceuticals, medical devices, and consumer health products, competing across several of Quest Pharmatech's key areas.

About

Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company's lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16 for the potential cancer targets, including pancreatic, colon, leukemia, ovarian, and breast cancer. Quest PharmaTech Inc. is headquartered in Edmonton, Canada.
Show more...
CEO
Dr. Ragupathy Madiyalakan Ph.D.
Country
CA
ISIN
CA74836M1068

Listings

OTC Link
US
QPTFF
V
CA
QPT.V

0 Comments

Share your thoughts

FAQ

What is Quest Pharmatech stock price today?▼
The current price of QPTFF is $0.03 USD — it has increased by +0% in the past 24 hours. Watch Quest Pharmatech stock price performance more closely on the chart.
What is Quest Pharmatech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Quest Pharmatech stocks are traded under the ticker QPTFF.
Is Quest Pharmatech stock price growing?▼
QPTFF stock has risen by +0% compared to the previous week, the month change is a +128.57% rise, over the last year Quest Pharmatech has showed a -24% decrease.
What is Quest Pharmatech market cap?▼
Today Quest Pharmatech has the market capitalization of 5.14M
What were Quest Pharmatech earnings last quarter?▼
QPTFF earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Quest Pharmatech revenue for the last year?▼
Quest Pharmatech revenue for the last year amounts to 0 USD.
What is Quest Pharmatech net income for the last year?▼
QPTFF net income for the last year is -2.51M USD.
In which sector is Quest Pharmatech located?▼
Quest Pharmatech operates in the Health Care sector.
When did Quest Pharmatech complete a stock split?▼
Quest Pharmatech has not had any recent stock splits.
Where is Quest Pharmatech headquartered?▼
Quest Pharmatech is headquartered in Edmonton, CA.